Top compounds associated with response to OR4C3


Feature Type Standardized
Nominal ANOVA
mRNA CUDC-101 GDSC1000 pan-cancer AAC 0.042 0.2
mRNA SN-38 CTRPv2 pan-cancer AAC 0.049 0.2
mRNA STF-62247 GDSC1000 pan-cancer AAC 0.045 0.2
mRNA QS11 GDSC1000 pan-cancer AAC 0.047 0.2
mRNA KU-0063794 CTRPv2 pan-cancer AAC -0.047 0.2
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC 0.044 0.2
mRNA FR-180204 GDSC1000 pan-cancer AAC -0.046 0.2
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.039 0.2
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.049 0.2
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.046 0.2
Download CSV